Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma – Results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience-Reference-Cited by-同舟云学术

Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma – Results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience

Published:2013-08 Issue:12 Volume:49 Page:2698-2704
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Weeda V.B.,Murawski M.,McCabe A.J.,Maibach R.,Brugières L.,Roebuck D.,Fabre M.,Zimmermann A.,Otte J.B.,Sullivan M.,Perilongo G.,Childs M.,Brock P.,Zsíros J.,Plaschkes J.,Czauderna P.,Aronson D.C.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference30 articles.

1. Differential diagnosis of tumours and tumour-like lesions of liver in infancy and childhood;Edmonson;Am J Dis Child,1956

2. Review of the clinicopathologic features of fibrolamellar carcinoma;Torbenson;Adv Anat Pathol,2007

3. Fibrolamellar carcinoma of the liver: a tumour of adolescents and young adults with distinctive clinico-pathologic features;Craig;Cancer,1980

4. Hepatocellular carcinoma in young people;Farhi;Cancer,1983

5. Natural history of hepatocellular carcinoma including fibrolamellar and hepato-cholangiocarcinoma variants;Okuda;J Gastroenterol Hepatol,2002

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence and survival of pediatric and adult hepatocellular carcinoma, United States, 2001–2020;Cancer Epidemiology;2024-10

2. Aggressive Surgical Management of Bilateral Metachronous Lung Metastases in Fibrolamellar Hepatocellular Carcinoma, a Case Report;Livers;2024-08-21

3. Neratinib Alone or in Combination with Immune Checkpoint Inhibitors with or without Mammalian Target of Rapamycin Inhibitors in Patients with Fibrolamellar Carcinoma;Liver Cancer;2024-08-08

4. Long-term survival and remarkably durable treatment response in a case of inoperable fibrolamellar carcinoma of the liver — a comprehensive analysis of an 8-year chemotherapeutic journey;Oncology in Clinical Practice;2024-05-24

5. Incidence and survival of pediatric and adult hepatocellular carcinoma, United States, 2001-2020;2024-03-27